Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04756193 · ClinicalTrials.gov registry record
Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound
A clinical trial of Covid19 and Echocardiography, sponsored by University of Louisville.
- Completed
- Registry status
- 98
- Enrollment target
- 1
- Study location
NCT04756193 is a study of Covid19 and Echocardiography that has completed, run by University of Louisville. The registered enrollment target is 98 participants, below the 2,701-participant average among 94 other Covid19 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04756193, a study of Covid19 and Echocardiography, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
We hypothesize that recovered COVID-19 patients suffer long term cardiovascular and pulmonary complications, which can be detected by point of care ultrasound. The goal is to comprehensively delineate the long term cardiovascular and pulmonary ultrasound findings in recovered COVID-19 patients, identify risks factors for prolonged heart/lung injury, evaluate long term effects of applied treatment, and assess late medication/vaccine side effects in COVID-19 patients.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound
Study Locations (1)
Kentucky
- University of Louisville Health - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2021-04-15 |
| Est. Completion | 2024-09-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04756193
The ClinicalTrials.gov registry entry for NCT04756193 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,701-participant average among 94 other Covid19 trials with a reported enrollment target (96% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which Point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound is the first listed.
NCT04756193 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT04756193 about?
NCT04756193 is a clinical study titled "Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound". We hypothesize that recovered COVID-19 patients suffer long term cardiovascular and pulmonary complications, which can be detected by point of care ultrasound. The goal is to comprehensively delineate the long term cardiovascular and pulmonary ultrasound findings in recovered COVID-19 patients, iden...
What is the current status of trial NCT04756193?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2021-04-15. Estimated completion is 2024-09-24.
What conditions does trial NCT04756193 study?
This clinical trial studies the following conditions: Covid19, Echocardiography, Ultrasound.
What interventions are being tested in trial NCT04756193?
The interventions under investigation include: Point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04756193?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04756193 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.